Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 04, 2024 09:00 ET | Source: Raydiant Oximetry

Raydiant Oximetry Oversubscribes Series A $7.5 Million Extension Round

Raydiant Oximetry, a clinical-stage medical device company, has oversubscribed a $7.5 million Series A3 extension round.
April 10, 2024 12:04 ET | Source: Raydiant Oximetry

Raydiant Oximetry Secures FDA Approval for Lumerah Investigational Device Exemption (IDE) Study

The FDA has approved the Investigational Device Exemption (IDE) of Lumerah for an Early Feasibility Study (EFS) of pregnant women during labor and delivery